[go: up one dir, main page]

DK1355626T3 - Veterinær, dermatologisk sammensætning - Google Patents

Veterinær, dermatologisk sammensætning

Info

Publication number
DK1355626T3
DK1355626T3 DK02710835T DK02710835T DK1355626T3 DK 1355626 T3 DK1355626 T3 DK 1355626T3 DK 02710835 T DK02710835 T DK 02710835T DK 02710835 T DK02710835 T DK 02710835T DK 1355626 T3 DK1355626 T3 DK 1355626T3
Authority
DK
Denmark
Prior art keywords
veterinary
dermatological composition
fur
skin
sphingoid base
Prior art date
Application number
DK02710835T
Other languages
Danish (da)
English (en)
Inventor
Jean-Claude Allart
Jean-Marie Lefevre
Jacques Peyrot
Original Assignee
Dermaconcept Jmc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8164268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1355626(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dermaconcept Jmc filed Critical Dermaconcept Jmc
Application granted granted Critical
Publication of DK1355626T3 publication Critical patent/DK1355626T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02710835T 2001-01-29 2002-01-29 Veterinær, dermatologisk sammensætning DK1355626T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2001/001019 WO2002060405A1 (fr) 2001-01-29 2001-01-29 Composition dermatologique veterinaire contenant une base sphingoide et/ou un derive de base sphingoide
PCT/EP2002/001120 WO2002060406A2 (fr) 2001-01-29 2002-01-29 Composition a usage dermatologique et veterinaire

Publications (1)

Publication Number Publication Date
DK1355626T3 true DK1355626T3 (da) 2007-05-07

Family

ID=8164268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02710835T DK1355626T3 (da) 2001-01-29 2002-01-29 Veterinær, dermatologisk sammensætning

Country Status (9)

Country Link
US (2) US8246972B2 (fr)
EP (1) EP1355626B1 (fr)
AT (1) ATE350106T1 (fr)
CA (1) CA2436414C (fr)
DE (1) DE60217292T2 (fr)
DK (1) DK1355626T3 (fr)
ES (1) ES2275846T3 (fr)
PT (1) PT1355626E (fr)
WO (2) WO2002060405A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010688A1 (it) * 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
JP2005535717A (ja) * 2002-08-14 2005-11-24 キム，テユン フィトスフィンゴシン誘導体を含むアポトーシス誘導用組成物
GB0513431D0 (en) 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses
DE102011109546A1 (de) * 2011-08-03 2013-02-07 Evonik Goldschmidt Gmbh Verwendung von Sphinganin zur Verbesserung des visuellen Erscheinungsbildes von Haut und Haar
KR101342851B1 (ko) 2011-12-07 2013-12-17 가톨릭대학교 산학협력단 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환, 자가면역질환 및 피부과다각화증질환 예방 및 치료용 조성물
KR101288776B1 (ko) * 2011-12-07 2013-07-22 가톨릭대학교 산학협력단 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환과 피부과다각화증질환 예방 및 개선용 화장료 조성물
EP3259990A1 (fr) * 2016-06-20 2017-12-27 Ceva Sante Animale Procédés pour lutter contre les ectoparasites chez les mammifères non humaines
WO2018177730A1 (fr) 2017-03-27 2018-10-04 Evonik Degussa Gmbh Procédé et produit pour la production de formulations contenant des céramides
EP3989955A1 (fr) * 2019-06-26 2022-05-04 Ceva Santé Animale Procédé de soin de la peau ou du pelage d'animaux

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007507C (fr) * 1989-02-03 1998-05-19 Yasuyuki Igarashi Sphingosine et n-methyl-sphingosine inhibiteurs de la croissance des cellules
EP0716589A4 (fr) * 1993-07-23 1997-06-11 Morris Herstein Composition cosmetique stimulant le renouvellement de la peau, avec effet prolonge d'elimination de l'irritation
DE19602111A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Mycota, Parasiten, Protozoen und Viren wirksame Zusammensetzungen auf der Basis von Squalen, Sphingolipiden und Fettsäuren
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
FR2747307B1 (fr) * 1996-04-11 1998-07-10 Ravi Shrivastava Application a titre de medicament des ceramides et compositions notamment pharmaceutiques les renfermant
BR9804872A (pt) * 1997-05-02 1999-08-24 Gist Brocades Bv Composi-{es antimicrobianas para uso tÄpico
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
US6306383B1 (en) 1998-09-16 2001-10-23 Wilson T Crandall Method for topical treatment of scars with protein kinase C inhibitors
BR0009265A (pt) * 1999-03-09 2001-11-20 Cosmoferm Bv Derivados com base em esfingóide e usos destes
US6361806B1 (en) * 2000-02-23 2002-03-26 Michael P. Allen Composition for and method of topical administration to effect changes in subcutaneous adipose tissue

Also Published As

Publication number Publication date
DE60217292T2 (de) 2007-05-31
EP1355626A2 (fr) 2003-10-29
PT1355626E (pt) 2007-03-30
ES2275846T3 (es) 2007-06-16
CA2436414C (fr) 2010-09-28
US9198855B2 (en) 2015-12-01
WO2002060406A2 (fr) 2002-08-08
ATE350106T1 (de) 2007-01-15
EP1355626B1 (fr) 2007-01-03
WO2002060405A8 (fr) 2003-10-30
US20050037035A1 (en) 2005-02-17
CA2436414A1 (fr) 2002-08-08
WO2002060405A1 (fr) 2002-08-08
US8246972B2 (en) 2012-08-21
DE60217292D1 (de) 2007-02-15
WO2002060406A8 (fr) 2003-10-30
US20130190401A1 (en) 2013-07-25
WO2002060406A3 (fr) 2003-02-20

Similar Documents

Publication Publication Date Title
BR0115452A (pt) Compostos tendo atividade fungicida e processos para fabricação e uso dos mesmos
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES2190803T3 (es) Iminas ciclicas como pesticidas.
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
HN1999000124A (es) Derivados de pirazol substituido.
BR0307429A (pt) Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3
BR9714390B1 (pt) composição fungicida, processo para a preparação da referida composição e método para o combate de fungos.
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
EA200100678A1 (ru) N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов
DE60314633D1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen
ATE415817T1 (de) Agrochemische formulierungen
NO20043013L (no) Tetrahydrokinolin analoger som muskarine agonister
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
SV2004001481A (es) Derivados de nicotinamida utiles como inhibidores de pde4" ref. pc22065a
DE60225077D1 (de) Topisches präparat
CO5221025A1 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contienen y su uso como agente para la lucha contra organismos daninos
DK1355626T3 (da) Veterinær, dermatologisk sammensætning
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
PA8514901A1 (es) Metabolitos agonistas/antagonistas de estrogeno
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR0209430A (pt) Compostos heterocìclicos
UY27770A1 (es) Imidazolinilmetil aralquilsulfonamidas